BioPharma Formulation & Delivery Nexus

About Us

Welcome to the forefront of innovation in pharmaceutical formulation and delivery! We are excited to invite you to the BioPharma Formulation & Delivery Nexus, a cutting-edge event set to take place on 14th-15th November, 2024 in the vibrant city of London, UK As the pharmaceutical industry continues to evolve rapidly, this conference serves as a pivotal platform for industry leaders, researchers, and innovators to convene and explore the latest advancements, strategies, and technologies shaping the future of drug formulation and delivery. Join us for insightful discussions, networking opportunities, and invaluable insights into the next generation of pharmaceutical products and therapies.

Our Worldwide Audience

Sector

Region

Job Function

Our Invited Speakers

Tomasz Grabowski

Head Preclinical Development

JJP Biologics

Richard Lewis

Director data science,CADD

Novartis

David Moreno Delgado

Associate Director Assay development and Technologies

Galapagos

John Castle

Chief Data & Information Officer

Monte Rosa Therapeutics

Andrea Aramini

Head of Research & Early Development – VP

Dompé

Henrik Moebitz

Associate Director Data Science

Novartis

Stefanie Urlinger

Chief Scientific Officer

Cimeio Therapeutics

Mazen Ahmad

Principal Scientist Discovery Data Sciences

The Janssen Pharmaceutical Companies of Johnson & Johnson

Nikki March

Senior Director of Scientific Affairs

GIO Therapeutics

Maria J. García-León

Senior Research Scientist

Domain Therapeutics

Sheila Soriano Santafe

Head of CMC

ARTHEx Biotech

Benefits Of Attending The Conference

Building Meaningful Relations

Stay Current with trends by Learning from Powerful Speakers

Connect with Influencers & in Turn, Your Target Audience

Get Fresh Ideas and Solutions for Your Business

Testimonials

This conference was very important for us because of the topics that were chosen for presentations and there were also qualified meetings and the meeting that we had was very relevant.

SATISH NAGRAJ

Associate Vice President

JUBILANT BIOSYS

The meeting here presented new technologies, new ways of drug discoveries, new ways of thinking of how to discover drugs and I gained a lot out of it. I hope that I will be able to follow up with that in the future.

MARK FEITELSON

CSO

SFA THERAPEUTICS

This has been a very rich, diverse and inspiring conference and networking opportunities were excellence. I can recommend the conference and wish the producers good luck in future.

TORSTEN HOFFMANN

CSO

SILENCE THERAPEUTICS

I would like to say that it was a very interesting, very good meeting with very different types of presentations coming from different angles bringing people together, very good discussions.

Geert Mudde

CSO & Founder

OncoQR ML

First time coming to this conference the organizers did a great job setting up one to one meetings with us and the company presentations the topics were relevant and look forward to coming back again next year

Jeff Goddard

VP, BD

AIT Bioscience

It was a program that had a great deal of scientific interest and leading edge technologies. I was a very impressive group of presenters and I was very happy that I was invited to present and it was a privilege to be so.

Don Van Dyke

COO

Cloud Pharmaceuticals

This is a very interesting and productive conference. I have learned a lot during these two days and met a lot of interesting people.I look forward to seeing the agenda of the next conference.